Compound Detail
CHEMBL328710
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL328710 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UAKWLVYMKBWHMX-PTNGSMBKSA-N |
9
Targets
27
Activities
3
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
264.3
MW (Da)
3.25
ALogP
2
HBA
1
HBD
32.3
PSA (Ų)
0.84
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 23 meas. best 6.2
Ki 3 meas. best 7.07
Kd 1 meas. best 4.71
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Alpha-synuclein CHEMBL6152 | Ki | 7.07 | 7.07 | 84.4 | 1 |
| Amyloid-beta precursor protein CHEMBL2487 | Ki | 7.04 | 7.04 | 91.6 | 1 |
| Microtubule-associated protein tau CHEMBL1293224 | Ki | 6.58 | 6.58 | 261.5 | 1 |
| Histone deacetylase 6 CHEMBL1865 | IC50 | 6.2 | 6.2 | 630.6 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL3516 | IC50 | 6.1 | 6.1 | 800.0 | 1 |
| Luciferin 4-monooxygenase CHEMBL5567 | IC50 | 6.1 | 5.38 | 800.0 | 5 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 5.43 | 5.34 | 3700.0 | 8 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.1 | 4.9833 | 7943.3 | 6 |
| Unchecked CHEMBL612545 | IC50 | 4.72 | 4.64 | 19000.0 | 2 |
| Unchecked CHEMBL612545 | Kd | 4.71 | 4.71 | 19500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24681390 | 10.1016/j.ejmech.2014.03.045 | Chorioallantoic membrane | 7 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 6 |
| 24894557 | 10.1016/j.bmcl.2014.05.005 | Chorioallantoic membrane | 5 |
| 18363348 | 10.1021/jm701302v | Luciferin 4-monooxygenase | 5 |
| 20092323 | 10.1021/jm9011142 | COLO 205 | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase mTOR | 4 |
| 23398362 | 10.1042/bj20121418 | cGMP-dependent protein kinase 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 5/CDK5 activator 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Protein kinase C beta type | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase HCK | 4 |
| 24681390 | 10.1016/j.ejmech.2014.03.045 | A549 | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin receptor | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Lck | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin-like growth factor 1 receptor | 4 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 4 |
| 24894557 | 10.1016/j.bmcl.2014.05.005 | A549 | 3 |
| 23398362 | 10.1042/bj20121418 | Fibroblast growth factor receptor 3 | 2 |
| 23398362 | 10.1042/bj20121418 | Fibroblast growth factor receptor 4 | 2 |
| 15456253 | 10.1021/jm049733a | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine